| Predicted Trait | |
| Reported Trait | Type 2 diabetes (T2D) | 
| Mapped Trait(s) | type 2 diabetes mellitus (MONDO_0005148) | 
| Score Construction | |
| PGS Name | PGS_T2D_beta_cell | 
| Development Method | |
| Name | Bayesian nonnegative matrix factorization using curated T2D GWAS variants and GWAS summary statistics of T2D-related traits | 
| Parameters | Minimum cluster weight of 0.75 | 
| Variants | |
| Original Genome Build | GRCh37 | 
| Number of Variants | 30 | 
| Effect Weight Type | beta | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000701 | 
| Citation (link to publication) | Loesch DP et al. Nat Commun (2025) | 
| Ancestry Distribution | |
| PGS Evaluation | |
| 
                          PGS Performance Metric ID (PPM)  | 
                    
                        
                          PGS Sample Set ID (PSS)  | 
                    
                        Performance Source | Trait | 
                          PGS Effect Sizes (per SD change)  | 
                    
                        Classification Metrics | Other Metrics | Covariates Included in the Model | 
                          PGS Performance: Other Relevant Information  | 
                    
                    
|---|---|---|---|---|---|---|---|---|
| PPM022306 | PSS011911| Multi-ancestry (including European)| 48,603 individuals  | 
                        
                            PGP000701 | Loesch DP et al. Nat Commun (2025)  | 
                        
                            Reported Trait: type 2 diabetes | OR: 1.27 [1.23, 1.31] | — | — | age, age^2, sex, UKB centre, array, genetic PCS 1-20 | — | 
| PPM022317 | PSS011912| European Ancestry| 45,356 individuals  | 
                        
                            PGP000701 | Loesch DP et al. Nat Commun (2025)  | 
                        
                            Reported Trait: type 2 diabetes | OR: 1.27 [1.23, 1.31] | — | — | age, age^2, sex, UKB centre, array, genetic PCS 1-20 | — | 
| 
                          PGS Sample Set ID (PSS)  | 
                    
                        Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS011911 | ICD10: E11 for T2D, N18 for CKD, first occurence of I20-125 for CAD. BMI: baseline body mass index | Median = 14.8 years | 48,603 individuals,  46.0 % Male samples  | 
                        
                            Mean = 56.8 years Sd = 8.2 years  | 
                        
                            European, East Asian, South Asian, Hispanic or Latin American, African unspecified | — | UKB | — | 
| PSS011912 | ICD10: E11 for T2D, N18 for CKD, first occurence of I20-125 for CAD, K76.0 for NAFLD. BMI: baseline body mass index | Median = 14.8 years | 45,356 individuals,  46.0 % Male samples  | 
                        
                            Mean = 57.1 years Sd = 8.1 years  | 
                        
                            European | — | UKB | — |